RecruitingNot Applicable

Myocardialbridge Bypass Graft Surgery Efficacy Verification

China500 participantsStarted 2020-01-01

Plain-language summary

Myocardial Bridge Bypass Graft surgery is introduced to relieve the unmedical symptoms of patients with long-segment or deep myocardial bridge, clinical outcomes will be collected to verify the effectiveness of the surgery.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with myocardialbridge requiring drug therapy or surgical intervention. Exclusion Criteria: * patients with myocardialbridge not requiring drug therapy or surgical intervention, or unwilling to be enrolled for any reason

What they're measuring

All-Cause Mortality

Timeframe: Up to 240 months

Rate of counduit patency

Timeframe: Up to 180 months

Trial details

NCT IDNCT06857838

SponsorXi'an International Medical Center Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-12-31

Contact for this trial

Zhen Wang, Doctorate

+86-029-68302464 wang.zhen@000516.cn

View on ClinicalTrials.gov More Myocardial Bridge of Coronary Artery trials